Written agreement from FDA for single-arm, open-label, baseline-controlled registrational trial evaluating composite primary endpoint of improvement in CGI-I and gain of developmental milestone/skill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback